PNPLA2 and colonic neoplasm: We found that blockade of ATGL-targeted pathways altered in human colonic tumors crypt base (Fig. 6C, IPA), suggesting that ATGL blockade may be effective for inhibiting the heterogenic human CCSC [59] from the colonic tumor crypt base.